Medicine
Silodosin 8 mg capsule
Silodosin 8 mg capsule is a generic prescription medicine for oral use, made by 12 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25ºC (68° to 77ºF), excursions permitted between 15º to 30ºC…
Key facts
- Active ingredient (INN)
- Silodosin
- Brand
- Sold under the generic name
- Strength
- 8 mg
- Dosage form
- Capsule
- Route
- Oral
- Packs
- 30 capsules, 90 capsules, 1000 capsules and 31 more
- Manufacturers
- Alembic PharmaceuticalsIndiaCamber PharmaceuticalsIndiaMacleods PharmaceuticalsIndiaAjanta PharmaIndiaAurobindo PharmaIndiaLupinIndiaNovadoz PharmaceuticalsIndiaAmneal Pharmaceuticals NYBryant Ranch PrepackCreekwood Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25ºC (68° to 77ºF), excursions permitted between 15º to 30ºC (59° to 86ºF). Protect from light and moisture.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- G04CA04 Silodosin
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 3 December 2018
- Identifiers
- RxCUI 809477, 826612DailyMed set ID ea3bbafb-d32a-d0d3-e053-2a95a90ac387, 455c98be-aa01-4393-915f-34d1859005c0, b9880aad-5fbe-470b-a7a0-d963ba4bc98b +12NDC 42291-778, 60219-1420, 31722-636 +12Application ANDA209745, ANDA204793, ANDA213230 +6
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 30 capsule in 1 bottle | 46708-406-30 | Alembic PharmaceuticalsIndia | 25 November 2019 |
| 90 capsule in 1 bottle | 46708-406-90 | Alembic PharmaceuticalsIndia | 25 November 2019 |
| 1000 capsule in 1 bottle | 46708-406-91 | Alembic PharmaceuticalsIndia | 25 November 2019 |
| 30 capsule in 1 bottle | 62332-406-30 | Alembic PharmaceuticalsIndia | 25 November 2019 |
| 90 capsule in 1 bottle | 62332-406-90 | Alembic PharmaceuticalsIndia | 25 November 2019 |
| 1000 capsule in 1 bottle | 62332-406-91 | Alembic PharmaceuticalsIndia | 25 November 2019 |
| 30 capsule in 1 bottle | 27241-145-01 | Ajanta PharmaIndia | 3 December 2018 |
| 90 capsule in 1 bottle | 27241-145-03 | Ajanta PharmaIndia | 3 December 2018 |
| 30 capsule in 1 bottle | 59651-096-30 | Aurobindo PharmaIndia | 10 December 2018 |
| 90 capsule in 1 bottle | 59651-096-90 | Aurobindo PharmaIndia | 10 December 2018 |
| 30 capsule in 1 bottle | 31722-636-30 | Camber PharmaceuticalsIndia | 14 February 2020 |
| 30 capsule in 1 bottle | 31722-636-31 | Camber PharmaceuticalsIndia | 14 February 2020 |
| 90 capsule in 1 bottle | 31722-636-90 | Camber PharmaceuticalsIndia | 14 February 2020 |
| 90 capsule in 1 bottle | 31722-636-91 | Camber PharmaceuticalsIndia | 14 February 2020 |
| 30 capsule in 1 bottle | 68180-741-06 | LupinIndia | 3 December 2018 |
| 90 capsule in 1 bottle | 68180-741-09 | LupinIndia | 3 December 2018 |
| 30 capsule in 1 bottle | 33342-385-07 | Macleods PharmaceuticalsIndia | 3 December 2018 |
| 90 capsule in 1 bottle | 33342-385-10 | Macleods PharmaceuticalsIndia | 3 December 2018 |
| 100 blister pack in 1 carton / 10 capsule in 1 blister pack | 33342-385-12 | Macleods PharmaceuticalsIndia | 3 December 2018 |
| 30 capsule in 1 bottle | 72205-010-30 | Novadoz PharmaceuticalsIndia | 3 December 2018 |
| 90 capsule in 1 bottle | 72205-010-90 | Novadoz PharmaceuticalsIndia | 3 December 2018 |
| 30 capsule in 1 bottle | 60219-1420-3 | Amneal Pharmaceuticals NY | 3 December 2018 |
| 90 capsule in 1 bottle | 60219-1420-9 | Amneal Pharmaceuticals NY | 3 December 2018 |
| 30 capsule in 1 bottle | 69238-1420-3 | Amneal Pharmaceuticals NY | 3 December 2018 |
| 90 capsule in 1 bottle | 69238-1420-9 | Amneal Pharmaceuticals NY | 3 December 2018 |
| 30 capsule in 1 bottle | 82619-114-01 | Creekwood Pharmaceuticals | 14 November 2024 |
| 90 capsule in 1 bottle | 82619-114-02 | Creekwood Pharmaceuticals | 14 November 2024 |
| 30 capsule in 1 bottle | 71335-3128-1 | Bryant Ranch Prepack | 29 April 2026 |
| 90 capsule in 1 bottle | 71335-3128-2 | Bryant Ranch Prepack | 29 April 2026 |
| 30 capsule in 1 bottle | 72162-2447-3 | Bryant Ranch Prepack | 14 November 2024 |
| 90 capsule in 1 bottle | 72162-2447-9 | Bryant Ranch Prepack | 14 November 2024 |
| 90 capsule in 1 bottle | 42291-778-90 | AvKARE | 4 October 2022 |
| 30 capsule in 1 bottle, plastic | 72789-090-30 | PD-Rx Pharmaceuticals | 23 June 2020 |
| 90 capsule in 1 bottle, plastic | 72789-090-90 | PD-Rx Pharmaceuticals | 23 June 2020 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Silodosin
Clinical summary
Silodosin is an alpha-adrenergic blocker indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH), among other approved uses. It is available as capsules for oral use. MedsAcross supplies Silodosin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about SilodosinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- SILODOSIN prescribing information (Novadoz Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
- Silodyx: European public assessment report (EPAR) · European Medicines Agency
- Urorec: European public assessment report (EPAR) · European Medicines Agency
Need Silodosin 8 mg capsule for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.